Biopraxis, Inc.

10655 Sorrento Valley Road, Suite 200
San Diego, CA 92121
10 Employees

SBIR Award Summary

Total Number of Awards 23
Total Value of Awards $6.9MM
First Award Date 08/12/96
Most Recent Award Date 02/15/07

Key Personnel

Last Name Name Awards Contact
Grow Ms. Ann E. Grow 17 Message
Black James A. Black 5 Message
Thompson Peggy A Thompson 6 Message

23 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-05-14
Budget: 02/15/07 - 02/14/09

DESCRIPTION (provided by applicant): NIH is seeking innovative methods for highly parallel detection of ligand/target binding, to develop a database of the biological activities of small organic molecules. Ribonucleic acids (RNAs) are involved in many critical aspects of normal cellular function, genetic disorders, and microbial infection. Like ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/06 - 08/31/08

DESCRIPTION (provided by applicant): High-throughput screening (HIS) assays for drug discovery and development rely on labels to determine whether a compound binds to the drug target. Label-based assays are time- and labor-intensive, yield limited information, and consume large amounts of expensive biomolecules and chemical libraries. Almost eve...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/06 - 07/31/08

DESCRIPTION (provided by applicant): Biopraxis proposes to develop its platform mu/SERS TM technology as a high-throughput biochip for screening large populations and large numbers of environmental samples for diverse chemical contaminants, including heavy metals, PCBs, pesticides, antibiotic residues, and naturally occurring toxins. Unlike othe...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-89
Budget: 08/01/06 - 07/31/08

DESCRIPTION (provided by applicant): New methods for studying gene and protein expression, such as DNA and protein microarrays, have revolutionized the study of biological processes. Carbohydrate expression profiling could have a huge impact; however, carbohydrates are exceptionally difficult to analyze. Biopraxis proposes to develop a new, labe...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-05-14
Budget: 02/15/06 - 02/14/07

DESCRIPTION (provided by applicant): NIH is seeking innovative methods for highly parallel detection of ligand/target binding, to develop a database of the biological activities of small organic molecules. Ribonucleic acids (RNAs) are involved in many critical aspects of normal cellular function, genetic disorders, and microbial infection. Like ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/05 - 08/31/06

DESCRIPTION (provided by applicant): High-throughput screening (HIS) assays for drug discovery and development rely on labels to determine whether a compound binds to the drug target. Label-based assays are time- and labor-intensive, yield limited information, and consume large amounts of expensive biomolecules and chemical libraries. Almost eve...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-89
Budget: 08/01/05 - 07/31/06

DESCRIPTION (provided by applicant): New methods for studying gene and protein expression, such as DNA and protein microarrays, have revolutionized the study of biological processes. Carbohydrate expression profiling could have a huge impact; however, carbohydrates are exceptionally difficult to analyze. Biopraxis proposes to develop a new, labe...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/05 - 07/31/06

DESCRIPTION (provided by applicant): Biopraxis proposes to develop its platform mu/SERS TM technology as a high-throughput biochip for screening large populations and large numbers of environmental samples for diverse chemical contaminants, including heavy metals, PCBs, pesticides, antibiotic residues, and naturally occurring toxins. Unlike othe...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-01-52
Budget: 07/01/05 - 06/30/07

DESCRIPTION (provided by applicant): Biopraxis proposes to develop its mu SERS platform technology as a high-throughput mix-and-measure screening (HTS) assay for antiviral drug lead identification and optimization. Unlike current HTS assays, mu SERS does not rely on labels. Instead, surface-enhanced Raman fingerprints are collected directly from...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/04 - 07/31/05

DESCRIPTION (provided by applicant): Biopraxis proposes to develop its platform mu/SERS TM technology as a high-throughput biochip for screening large populations and large numbers of environmental samples for diverse chemical contaminants, including heavy metals, PCBs, pesticides, antibiotic residues, and naturally occurring toxins. Unlike othe...

Load More